Calamos Wealth Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,258	Closed	-$562K	–	271
2020 Q1	$562K	Sell	6,258 -22,574	-78%	-$2.22M	0.09%	142
2019 Q4	$3.12M	Buy	28,832 +241	+0.8%	+$25.8K	0.37%	70
2019 Q3	$2.8M	Buy	28,591 +498	+2%	+$56.1K	0.37%	74
2019 Q2	$3.68M	Buy	28,093 +583	+2%	+$75.1K	0.5%	57
2019 Q1	$3.72M	Buy	27,510 +4,834	+21%	+$601K	0.53%	56
2018 Q4	$2.21M	Buy	+22,676	New	+$2.68M	0.33%	70
2016 Q4	–	Sell	-5,695	Closed	-$698K	–	235
2016 Q3	$698K	Sell	5,695 -6,658	-54%	-$857K	0.12%	166
2016 Q2	$1.44M	Sell	12,353 -490	-4%	-$69.5K	0.25%	132
2016 Q1	$1.79M	Buy	12,843 +907	+8%	+$133K	0.34%	96
2015 Q4	$2.28M	Buy	11,936 +5,651	+90%	+$987K	0.45%	63
2015 Q3	$983K	Buy	6,285 +3,813	+154%	+$696K	0.24%	142
2015 Q2	$447K	Buy	+2,472	New	+$427K	0.11%	184